Plus d’un million de livres à portée de main !
Bookbot

Sam Salek

    Benefit-Risk Assessment of Medicines
    Compendium of Quality of Life Instruments Network Update 51 - 100 User
    Compendium of Quality of Life Instruments Network 21 - 50 User
    Compendium of Quality of Life Instruments Network Update 11 - 20 User
    • Focusing on the measurement of quality of life, this resource compiles approximately 200 research instruments utilized in studies. It evaluates each instrument for reliability and validity, providing insights into their strengths and weaknesses. This comprehensive guide serves as an essential tool for researchers seeking to understand and assess quality of life through various methodologies.

      Compendium of Quality of Life Instruments Network Update 11 - 20 User
    • This resource for researchers compiles approximately 200 instruments designed to assess quality of life. It evaluates each instrument's reliability and validity, providing a thorough analysis of their strengths and weaknesses. By detailing the advantages and drawbacks of various tools, it serves as a comprehensive guide for those conducting studies in this field.

      Compendium of Quality of Life Instruments Network 21 - 50 User
    • Focusing on the measurement of quality of life, this resource compiles approximately 200 research instruments utilized in studies. It evaluates each instrument's reliability and validity, providing insights into their strengths and weaknesses. The comprehensive examination aids researchers in selecting appropriate tools for their studies, highlighting both the advantages and limitations of various instruments.

      Compendium of Quality of Life Instruments Network Update 51 - 100 User
    • Benefit-Risk Assessment of Medicines

      The Development and Application of a Universal Framework for Decision-Making and Effective Communication

      • 332pages
      • 12 heures de lecture

      This book presents a universal framework for benefit-risk decisions in pharmaceuticals, addressing the need for a structured approach. It reviews current methodologies and evaluates their effectiveness, offering insights from regulatory authorities. The aim is to create a harmonized system for global benefit-risk assessment.

      Benefit-Risk Assessment of Medicines